Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised Nick’s in connection with fund raising
Mandate

Vinge has advised Nick’s in connection with fund raising

March 11, 2021 Capital Markets and Public M&A

Vinge has advised Nick’s, a food-tech brand offering sugar free snacks and ice cream, in connection with its largest investment round of USD 30 million.

The new round was led by Stockholm-based investment group Gullspång Invest, and Capagro. The funds will be used to fuel the company’s international expansion with primary focus on the US, Germany and to build a new production facility in Europe.

Vinge’s team consisted of, among others, Kristina Ekberg, Maria Dahlin Kolvik and Jonathan Riddersholm.

 

Related

Vinge advises Trianon in connection with directed share issue and tender offer for subordinated sustainable capital securities

 Vinge advises Fastighets Aktiebolaget Trianon (publ) in connection with a directed share issue of SEK 184 million and a tender offer for outstanding subordinated perpetual floating rate callable sustainable capital securities.
April 19, 2024

Vinge advises Blackstone in connection with its investment in Winthrop Technologies

 Vinge, as local Swedish counsel, advised Blackstone Tactical Opportunities and affiliated funds (“Blackstone”) in connection with a strategic partnership with Winthrop Technologies Limited (“Winthrop Technologies”).
April 17, 2024

Vinge has advised Hansa Biopharma in connection with a directed share issue of SEK 372 million

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of SEK 372 million before transaction costs. Hansa Biopharma is a commercial-stage biopharmaceutical company pioneering the development and commercialization of innovative, lifesaving and life altering treatments for patients with rare immunological conditions. Hansa Biopharma’s ordinary share is listed on Nasdaq Stockholm.
April 16, 2024